Hoth Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Hoth Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Hoth Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $200.000, a 96.9% decline year-over-year.
  • Hoth Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $22.5K.
  • Hoth Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$153K, a 50% increase from 2022.
  • Hoth Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$306K, a 44.3% decline from 2021.
  • Hoth Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$212K, a 304% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$153K +$153K +50% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$306K -$94.1K -44.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$212K -$316K -304% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $104K +$93.8K +905% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $10.4K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.